Tokyo Tape
Sign in
← Delta-Fly Pharma

Annual report

4598.TEDINET S100TY6T
Period2023-04-01 → 2024-03-31
Filed2024-06-28
StandardJapan GAAP
ConsolidatedNo
Data checks11 of 11 passed
Key figures · 72
MetricValuePeriodScopeSource row
Operating income−¥1.4bn2023-04-01 → 2024-03-31StandaloneOperating income
Operating income−¥1.3bn2022-04-01 → 2023-03-31StandaloneOperating income
Ordinary income−¥1.4bn2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income−¥1.3bn2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income−¥964m2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥859m2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.6bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.4bn2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Profit before tax−¥1.3bn2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Net income−¥1.4bn2023-04-01 → 2024-03-31StandaloneProfit loss
Net income−¥1.3bn2022-04-01 → 2023-03-31StandaloneProfit loss
Net income−¥967m2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income−¥863m2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income−¥1.6bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Total assets¥1.5bnat 2024-03-31StandaloneAssets
Total assets¥907mat 2023-03-31StandaloneAssets
Total assets¥1.3bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥2.2bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥2.2bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥241mat 2024-03-31StandaloneLiabilities
Total liabilities¥116mat 2023-03-31StandaloneLiabilities
Net assets / equity¥1.2bnat 2024-03-31StandaloneNet assets
Net assets / equity¥791mat 2023-03-31StandaloneNet assets
Net assets / equity¥1.2bnat 2022-03-31dStandaloneNet assets
Net assets / equity¥2.1bnat 2021-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥2.1bnat 2020-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥1.4bnat 2024-03-31StandaloneCash and deposits
Cash and deposits¥844mat 2023-03-31StandaloneCash and deposits
Cash & equivalents¥1.4bnat 2024-03-31StandaloneCash and cash equivalents
Cash & equivalents¥844mat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.3bnat 2022-03-31dStandaloneCash and cash equivalents
Cash & equivalents¥2.1bnat 2021-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.9bnat 2020-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.3bn2023-04-01 → 2024-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.3bn2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥940m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥727m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.6bn2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow¥207,0002023-04-01 → 2024-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥326,0002022-04-01 → 2023-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥505,0002020-04-01 → 2021-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥13m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥1.9bn2023-04-01 → 2024-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥883m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥120m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥875m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥100m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-198.782023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-234.512022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-178.582021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-187.342020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-348.322019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥149.69at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥123.91at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥227.41at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥390.87at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥456.47at 2020-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio83.6%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio87.0%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio93.1%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio96.1%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio95.1%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued8,229,900at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued6,369,600at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued5,419,600at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued5,314,600at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued4,504,600at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees13at 2024-03-31StandaloneNumber of employees
Employees11at 2023-03-31StandaloneNumber of employees
Employees12at 2022-03-31dStandaloneNumber of employees
Employees11at 2021-03-31dStandaloneNumber of employees
Employees13at 2020-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 724
ItemContextValueUnit
Compensations sgaPrior1YearDuration_NonConsolidatedMember39570000JPY
Compensations sgaCurrentYearDuration_NonConsolidatedMember28535000JPY
Taxes and dues sgaPrior1YearDuration_NonConsolidatedMember43374000JPY
Taxes and dues sgaCurrentYearDuration_NonConsolidatedMember56262000JPY
Patent costs sgaPrior1YearDuration_NonConsolidatedMember40596000JPY
Patent costs sgaCurrentYearDuration_NonConsolidatedMember37079000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)四国財務局長
Filing date cover pageFilingDateInstant2024-06-28
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第14期(自　2023年４月１日　至　2024年３月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)Ｄｅｌｔａ－Ｆｌｙ　Ｐｈａｒｍａ　株式会社
Company name in english cover pageFilingDateInstantＤｅｌｔａ－Ｆｌｙ　Ｐｈａｒｍａ, Ｉｎｃ．
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　江島　淸
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)徳島県徳島市川内町宮島錦野37番地の５
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)088－637－1055(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役　管理部門担当　黒滝　健一
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都中央区日本橋本町３丁目11番５号日本橋ライフサイエンスビルディング２　６階
Telephone number nearest place of contact cover pageFilingDateInstant03－6231－1278
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役　管理部門担当　黒滝　健一
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE34318
Fund codeFilingDateInstant－
Security codeFilingDateInstant45980
Filer name in japaneseFilingDateInstant
Original text (Japanese)Ｄｅｌｔａ－Ｆｌｙ　Ｐｈａｒｍａ　株式会社
Filer name in englishFilingDateInstantDelta-Fly Pharma,Inc.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第三号様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstantfalse
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Current fiscal year start dateFilingDateInstant2023-04-01
Current period end dateFilingDateInstant2024-03-31
Type of current periodFilingDateInstantFY
Current fiscal year end dateFilingDateInstant2024-03-31
Previous fiscal year start dateFilingDateInstant2022-04-01
Comparative period end dateFilingDateInstant2023-03-31
Previous fiscal year end dateFilingDateInstant2023-03-31
Next fiscal year start dateFilingDateInstant－
End date of quarterly or semi annual period of next fiscal yearFilingDateInstant－
Amendment flagFilingDateInstantfalse
Identification of document subject to amendmentFilingDateInstant－
Report amendment flagFilingDateInstantfalse
Xbrl amendment flagFilingDateInstantfalse
Business results of reporting company (text)FilingDateInstantText · Plus
Company history (text)FilingDateInstantText · Plus
Description of business (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 11 of 11 passed
balance sheet identitynon_consolidated 2023-03-31pass
balance sheet identitynon_consolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass